Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
11.13
-0.20 (-1.77%)
At close: Feb 21, 2025, 4:00 PM
11.20
+0.07 (0.63%)
After-hours: Feb 21, 2025, 4:29 PM EST
Wave Life Sciences Employees
As of December 31, 2023, Wave Life Sciences had 268 total employees, including 266 full-time and 2 part-time employees. The number of employees increased by 16 or 6.35% compared to the previous year.
Employees
268
Change (1Y)
16
Growth (1Y)
6.35%
Revenue / Employee
$200,037
Profits / Employee
-$531,780
Market Cap
1.70B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
WVE News
- 16 days ago - Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity - GlobeNewsWire
- 6 weeks ago - Wave Life Sciences Is A Buy On Pipeline Prospects - Seeking Alpha
- 2 months ago - Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity - GlobeNewsWire
- 2 months ago - Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Wave Life Sciences to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 3 months ago - Wave Life Sciences Ltd. (WVE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs - GlobeNewsWire
- 4 months ago - Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst - Seeking Alpha